Conference
Agenda
DAY 1
FINAL AGENDA
DAY 1
CANCER POLICY IN THE COVID-19 ERA
| 09.15 – 09.30 | OPENING REMARKS |
| Conference Moderator: | Nelly Kapsi, Editor in Chief, Health Daily |
| Thanos Plevris, Minister of Health, Ministry of Health Greece | |
| Michalis Hadjipandelas, Minister of Health, Ministry of Health Cyprus | |
| Stella Kyriakides, Commissioner, Health and Food Safety | |
09.30 – 11:30 |
SESSION 1 | MAKING CANCER FIGHT A POLICY PRIORITY |
| Moderator: | Nelly Kapsi, Editor in Chief, Health Daily |
Keynote Speeches |
|
| Amanda Psyrri, ESMO Nomination Committee Chair, Associate Professor of Medical Oncology, National Kapodistrian University of Athens, Medical School, Chief of Oncology, Attikon University Hospital | |
| Elena Kountoura, Member of the European Parliament, President, Europa Donna Hellas | |
Panelists |
|
| Εvangelos Filopoulos, President, Hellenic Cancer Society, Surgeon, Director of the Breast Cancer Clinic “Agios Savvas” | |
| Maria Ioannidou, Executive Director of the Cyprus Anti-Cancer Society | |
| Kathi Apostolidis, President, ELLOK, Board Member, ECPC European Cancer Patient Coalition | |
| 11:30 – 12:30 | Expo – Networking Break |
12:30 – 14:15 |
SESSION 2 | CANCER DRUG DEVELOPMENT: HOW CAN PUBLIC ORGANIZATIONS, ACADEMIA AND INDUSTRY WORK TOGETHER |
| Moderator: | Nikolaos Tsoukalas, MD, MSc, PhD, Medical Oncologist, MSc Bioinformatics, Deputy Director, Oncology Department, 401 General Military Hospital, Consultant, ‘Henry Dunant’ Hospital Center, Athens Greece, Vice President Hellenic Society of Medical Oncology (Hesmo) |
| Dimitris Philippou, MD, Phd. President, National Organization for Medicines (EOF), Assistant Professor of Anatomy and Surgical Anatomy at the Medical School of the National Kapodistrian University of Athens, President of the Medicines Negotiations Committee and Executive Member of KESY | |
| Assessing the Value of Advanced Treatments in Oncology Panos Stafylas, Scientific Director, HealThink |
|
| Access to innovation in Oncology: From R&D to clinical practice Zefi Vlachopioti, Country Market Access Lead, Bristol-Myers Squibb |
|
| The Value of Innovation in Oncology Andonis Karokis, External Affairs Director, MSD Greece |
|
| Advancing Personalised Approaches in Oncology in Greece Socrates Koulouris, Chief Medical Value Officer, Roche |
|
| In the era of precision medicine, biomarkers play a key role for patients’ access to innovation Christos Antonopoulos, MD, PhD, EMBA, Director Oncology Business Unit, AstraZeneca |
|
| 14:15 – 15:00 | Expo – Networking Break |
15:00 – 16.15 |
SESSION 3 | THE FUTURE OF CANCER DIAGNOSIS AND TREATMENT |
| Moderator: | Helena Linardou, MD PhD, PhD Imperial College London, Medical Oncologist, Director- 4th Oncology Dept. & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Founding Board Member W4O-Hellas |
| Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer Petros Christopoulos, Assistant Professor of Medical Oncology, Heidelberg University |
|
| Treatment of tumors associated with VHL disease Othon Iliopoulos, Associate Professor of Medicine, Harvard Medical School, Center for Cancer Research, Massachusetts General Hospital |
|
| The Introduction of the PRS (Polygenic Risk Score) in Cancer Prevention Asimina Ηiona, MSc, PhD Doctor of Biochemistry / Molecular Biology, Business Development Manager, Center for Preventive Medicine & Longevity, BIOIATRIKI HEALTHCARE Group |
|
| 16:15 | Closing Remarks |
Χορηγίες – Συμμετοχές
Χρυσούλα Κορδούλη, Τ: +30 210 6617 777 (ext. 204), fax: +30 210 6617 778, E: [email protected]
Νίκος Τσάκωνας, M: +30 6936123475 , E: [email protected]
Χορηγίες – Συμμετοχές για Κύπρο
Συμμετοχές: Έλενα Χατζηνικολάου, T. (+357) 96494925, [email protected]
Χορηγίες: Γιώργος Λοϊζου, T. (+357) 99 103323, E. [email protected]
Πληροφορίες
Ναταλία Τουμπανάκη, Τ: +30 210 6617 777 (ext. 289), F: 210 6617778, E: [email protected]
Νέλλη Καψή, Τ: 210 6617777 (εσωτ. 204), F: 210 6617778, E: [email protected]
BOUSSIAS
Κλεισθένους 338, 15344, Γέρακας, Αττική, Ελλάδα+30 210 6617777
+30 210 6617778
www.boussias.com